Treatment with Recombinant Hsp72 Suppresses Collagen-Induced Arthritis in Mice
- 18 September 2010
- journal article
- research article
- Published by Springer Nature in Inflammation
- Vol. 34 (5) , 432-439
Abstract
Although the level of heat shock protein (Hsp72) has been shown to be enhanced in rheumatoid arthritis (RA) synovial tissues and RA synovial fluid, it remains unclear what role extracellular Hsp72 plays in the pathogenesis of RA. This study was conducted to investigate the effects of recombinant human Hsp72 on collagen-induced arthritis (CIA) when administered therapeutically and elucidate its underlying mechanism. We demonstrated that recombinant Hsp72 significantly reduced disease severity. Hsp72-treated animals displayed significantly less cartilage and bone destruction than that in the controls. Hsp72 treatment also reduced the expression of tumor necrosis factor alpha and interleukin 6 in the sera. Furthermore, Hsp72 treatment significantly inhibited activation of nuclear factor kappa B (NF-κB) in synovial tissues of CIA mice. These findings suggest that recombinant Hsp72 effectively suppressed synovial inflammation and the development and progress of CIA, which is mediated through the reduction of production of proinflammatory cytokines and the suppression of activation of NF-κB pathway.Keywords
This publication has 41 references indexed in Scilit:
- Extracellular heat shock protein 70 inhibits tumour necrosis factor-α induced proinflammatory mediator production in fibroblast-like synoviocytesArthritis Research & Therapy, 2008
- BiP regulates autoimmune inflammation and tissue damageAutoimmunity Reviews, 2006
- Stress cytokines: pivotal proteins in immune regulatory networksCurrent Opinion in Immunology, 2004
- The role of the interleukin‐6 family of cytokines in inflammatory arthritis and bone turnoverArthritis & Rheumatism, 2003
- The role of TNF‐α in the pathogenesis of inflammation and joint destruction in rheumatoid arthritis (RA): a study using a human RA/SCID mouse chimeraRheumatology, 2002
- The Effect of Dexamethasone on the Expression of Activated NF-κB in Adjuvant ArthritisClinical Immunology and Immunopathology, 1997
- Manipulation of Distinct NFκB Proteins Alters Interleukin-1β-induced Human Rheumatoid Synovial Fibroblast Prostaglandin E2 FormationJournal of Biological Chemistry, 1996
- Activation of the transcription factor nuclear factor‐κB in human inflamed synovial tissueArthritis & Rheumatism, 1996
- Activation of transcription factor NF‐κB in human synovial cells in response to tumor necrosis factor αArthritis & Rheumatism, 1996
- Nuclear factor–kB in rheumatoid synovium. Localization of P50 and P65Arthritis & Rheumatism, 1995